Balchem Corporation is a specialty chemicals business based in the US. Balchem Corporation shares (BCPC) are listed on the NASDAQ and all prices are listed in US Dollars. Balchem Corporation employs 1,355 staff and has a trailing 12-month revenue of around $1 billion.
Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 45 days, you’ll no longer qualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Probability percentage is subject to decrease.
Terms and conditions apply*. For 401k rollovers, existing SoFi IRA members must complete 401k rollovers via this link For SoFi members without a SoFi IRA, a SoFi IRA must first be opened, and 401k rollover must be completed utilizing Capitalize via this link. SoFi and Capitalize will charge no additional fees to process a 401(k) rollover to a SoFi IRA. SoFi is not liable for any costs incurred from the existing 401k provider for rollover. Please check with your 401k provider for any fees or costs associated with the rollover. For IRA contributions, only deposits made via ACH and cash transfer from SoFi Bank accounts are eligible for the match. Click here for the 1% Match terms and conditions.
Trade stocks, ETFs, options, futures and bonds all in one place
$0 commissions on stocks, ETFs and equity options, with low contract fees
Deposit or transfer $10,000+ to earn a 2% Match Bonus. Plus: Get a $100 transfer fee reimbursement on your first brokerage transfer of $2,000 or more. T&C apply.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Balchem Corporation stock price (NASDAQ: BCPC)
Use our graph to track the performance of BCPC stocks over time.
Is it a good time to buy Balchem Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Is Balchem Corporation stock undervalued or overvalued?
Valuing Balchem Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Balchem Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Balchem Corporation's P/E ratio
Balchem Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 34x. In other words, Balchem Corporation shares trade at around 34x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Balchem Corporation's PEG ratio
Balchem Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.8341. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Balchem Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Balchem Corporation's EBITDA
Balchem Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $249.7 million.
The EBITDA is a measure of a Balchem Corporation's overall financial performance and is widely used to measure a its profitability.
Balchem Corporation financials
Revenue TTM
$1 billion
Operating margin TTM
20.4%
Gross profit TTM
$363.1 million
Return on assets TTM
7.87%
Return on equity TTM
12.06%
Profit margin
14.72%
Book value
$40.09
Market Capitalization
$5.1 billion
TTM: trailing 12 months
Balchem Corporation share dividends
Dividend payout ratio: 17.51% of net profits
Recently Balchem Corporation has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Balchem Corporation shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Balchem Corporation's case, that would currently equate to about $0.87 per share.
While Balchem Corporation's payout ratio might seem low, this can signify that Balchem Corporation is investing more in its future growth.
Balchem Corporation's most recent dividend payout was on 16 January 2025. The latest dividend was paid out to all shareholders who bought their shares by 25 December 2024 (the "ex-dividend date").
Have Balchem Corporation's shares ever split?
Balchem Corporation's shares were
split on a 3:2 basis on 20 January 2010
. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Balchem Corporation shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Balchem Corporation shares which in turn could have impacted Balchem Corporation's share price.
Balchem Corporation share price volatility
Over the last 12 months, Balchem Corporation's shares have ranged in value from as little as $139.17 up to $179.7994. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Balchem Corporation's is 0.994. This would suggest that Balchem Corporation's shares are less volatile than average (for this exchange).
Balchem Corporation overview
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices.
Frequently asked questions
null What percentage of Balchem Corporation is owned by insiders or institutions? Currently 0.37% of Balchem Corporation shares are held by insiders and 92.625% by institutions.How many people work for Balchem Corporation? Latest data suggests 1,355 work at Balchem Corporation.When does the fiscal year end for Balchem Corporation? Balchem Corporation's fiscal year ends in December.Where is Balchem Corporation based? Balchem Corporation's address is: 5 Paragon Drive, Montvale, NJ, United States, 07645What is Balchem Corporation's ISIN number? Balchem Corporation's international securities identification number is: US0576652004What is Balchem Corporation's CUSIP number? Balchem Corporation's Committee on Uniform Securities Identification Procedures number is: 057665200
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
